SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-250720
Filing Date
2019-09-20
Accepted
2019-09-20 16:32:56
Documents
4
Period of Report
2019-09-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d806988d8k.htm 8-K 30966
2 EX-10.1 d806988dex101.htm EX-10.1 97174
3 EX-99.1 d806988dex991.htm EX-99.1 19969
4 GRAPHIC g806988g26j09.jpg GRAPHIC 12364
  Complete submission text file 0001193125-19-250720.txt   166569
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35409 | Film No.: 191105091
SIC: 2834 Pharmaceutical Preparations